Galmed Pharmaceuticals Stock (NASDAQ:GLMD), Quotes and News Summary

Q: What sector and industry does Galmed Pharmaceuticals (GLMD) operate in?

Galmed Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Galmed Pharmaceuticals Stock (NASDAQ: GLMD) stock price, news, charts, stock research, profile.

Open	$0.383
Close	$0.352
Volume / Avg.	30.455K / 209.550K
Day Range	0.352 - 0.399
52 Wk Range	0.260 - 7.800
Market Cap	$2.398M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	0.68%
Days to Cover	1

Recent News

Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket

Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter.

Avi Kapoor

Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on Monday.

Avi Kapoor

Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL® tablets in diverse populations.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

2.8

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Galmed Pharmaceuticals (GLMD) stock?

You can purchase shares of Galmed Pharmaceuticals (NASDAQ: GLMD) through any online brokerage.

View our list of the best stock brokerages.

Who are Galmed Pharmaceuticals's (GLMD) competitors?

There are no as such competitors for Galmed Pharmaceuticals.

What is the target price for Galmed Pharmaceuticals (GLMD) stock?

The latest price target for Galmed Pharmaceuticals (NASDAQ: GLMD) was reported by Maxim Group on Monday, July 24, 2023. The analyst firm set a price target for 4.00 expecting GLMD to rise to within 12 months (a possible 902.51% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Galmed Pharmaceuticals (GLMD)?

The stock price for Galmed Pharmaceuticals (NASDAQ: GLMD) is $0.399 last updated April 30, 2024 at 4:16 AM EDT.

Does Galmed Pharmaceuticals (GLMD) pay a dividend?

There are no upcoming dividends for Galmed Pharmaceuticals.

When is Galmed Pharmaceuticals (NASDAQ:GLMD) reporting earnings?

Galmed Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 30, 2024.

Is Galmed Pharmaceuticals (GLMD) going to split?

There is no upcoming split for Galmed Pharmaceuticals.

What sector and industry does Galmed Pharmaceuticals (GLMD) operate in?

Galmed Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.